News | May 20, 2025
Zydus Wellness records a growth of 30% in net profit in FY25
EBITDA for the period rose by 23.2% to Rs. 3,797 million
EBITDA for the period rose by 23.2% to Rs. 3,797 million
These observations are procedural in nature and none of them are related to data integrity
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
The company does not expect this development to have any material impact on the current business operations
The unique soap-fusion of Gondhoraj lime and neem provides a refreshing skin-friendly experience
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
The observations issued are neither repeated observations nor related to data integrity
This collaboration aims to bridge modern scientific research with traditional Ayurvedic wisdom, fostering innovative solutions that support holistic well-being
EBITDA rose to Rs. 14.8 crore, marking a 16.5% y-o-y increase, while net profit surged to Rs. 6.4 crore
Subscribe To Our Newsletter & Stay Updated
